Archer-Daniels-Midland vs Eli Lilly and Company
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Archer-Daniels-Midland (ADM) carries a "Neutral" signal with +2.8% revenue growth, while Eli Lilly and Company (LLY) is "Tailwind" with +73.1% revenue growth. Both companies report in the Consumer Staples and Healthcare sectors.
| Metric | Archer-Daniels-Midland (ADM) | Eli Lilly and Company (LLY) |
|---|---|---|
| Operator Signal | Neutral | Tailwind |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $20.5B | $19.8B |
| Revenue Growth | 2.8% | 73.1%* |
| Latest EPS | $0.62 | $8.26* |
| EPS Growth | 1450.0%* | 672.0% |
| Sector | Consumer Staples | Healthcare |
| Quarters Tracked | 8 | 8 |
Archer-Daniels-Midland (ADM) carries a "Neutral" signal with +2.8% revenue growth, while Eli Lilly and Company (LLY) is "Tailwind" with +73.1% revenue growth. Both companies report in the Consumer Staples and Healthcare sectors.